Changing epidemiology of nontuberculous mycobacterial lung disease in South Korea

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 10, 2012, Pages 733-738

  Lee, Sang Kook ^a   Lee, Eun Ja ^a   Kim, Se Kyu ^a   Chang, Joon ^a   Jeong, Seok Hoon ^a   Kang, Young Ae ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Culture method; Epidemiology; Nontuberculous mycobacteria

Indexed keywords

ADULT; AGED; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIUM CULTURE; BACTERIUM ISOLATE; FEMALE; HOSPITAL PATIENT; HUMAN; INCIDENCE; LIQUID CULTURE; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OBSERVATIONAL STUDY; OUTPATIENT; RETROSPECTIVE STUDY; SOUTH KOREA; TERTIARY HEALTH CARE; TREND STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; PNEUMONIA, BACTERIAL; REPUBLIC OF KOREA; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84866656301     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2012.681695     Document Type: Article

References (24)

1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367-416.
2. Falkinham JO 3rd. Nontuberculous mycobacteria in the environment. Clin Chest Med 2002;23:529-51.
3. Saleeb P, Olivier KN. Pulmonary nontuberculous mycobac-terial disease: new insights into risk factors for susceptibility, epidemiology, and approaches to management in immuno-competent and immunocompromised patients. Curr Infect Dis Rep 2010;12:198-203.
4. Khan K, Wang J, Marras TK. Nontuberculous mycobacterial sensitization in the United States: national trends over three decades. Am J Respir Crit Care Med 2007;176:306-13.
5. Billinger ME, Olivier KN, Viboud C, de Oca RM, Steiner C, Holland SM, et al. Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005. Emerg Infect Dis 2009;15:1562-9.
6. Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003. Thorax 2007;62:661-6.
7. Martin-Casabona N, Bahrmand AR, Bennedsen J, Thomsen VO, Curcio M, Fauville-Dufaux M, et al. Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis 2004;8:1186-93.
8. Thomson RM. Changing epidemiology of pulmonary non-tuberculous mycobacteria infections. Emerg Infect Dis 2010;16:1576-83.
9. Cook JL. Nontuberculous mycobacteria: opportunistic environmental pathogens for predisposed hosts. Br Med Bull 2010;96:45-59.
10. Ryoo SW, Shin S, Shim MS, Park YS, Lew WJ, Park SN, et al. Spread of nontuberculous mycobacteria from 1993 to 2006 in Koreans. J Clin Lab Anal 2008;22:415-20.
11. Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK, et al. Clinical signifi cance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006;129:341-8.
12. Sim YS, Park HY, Jeon K, Suh GY, Kwon OJ, Koh WJ. Standardized combination antibiotic treatment of Mycobac-terium avium complex lung disease. Yonsei Med J 2010; 51:888-94.
13. Lee H, Park HJ, Cho SN, Bai GH, Kim SJ. Species identi-fi cation of mycobacteria by PCR-restriction fragment length polymorphism of the rpo B gene. J Clin Microbiol 2000; 38:2966-71.
14. Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 2010;182: 970-6.
15. Chen CY, Chen HY, Chou CH, Huang CT, Lai CC, Hsueh PR. Pulmonary infection caused by nontuberculous myco-bacteria in a medical center in Taiwan, 2005-2008. Diagn Microbiol Infect Dis 2012;72:47-51.
16. Chihota VN, Grant AD, Fielding K, Ndibongo B, van Zyl A, Muirhead D, et al. Liquid vs. solid culture for tuberculosis: performance and cost in a resource-constrained setting. Int J Tuberc Lung Dis 2010;14:1024-31.
17. Sorlozano A, Soria I, Roman J, Huertas P, Soto MJ, Piedrola G, et al. Comparative evaluation of three culture methods for the isolation of mycobacteria from clinical samples. J Micro-biol Biotechnol 2009;19:1259-64.
18. The Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: revised 2011. GOLD; 2011. Available at: http://www.gold-copd. org/(accessed May 1 2012).
19. Seitz AE, Olivier KN, Adjemian J, Holland SM, Prevots DR. Trends in bronchiectasis among Medicare benefi ciaries in the United States, 2000-2007. Chest 2012 Feb 2. [Epub ahead of print]
20. Salvana EM, Cooper GS, Salata RA. Mycobacterium other than tuberculosis (MOTT) infection: an emerging disease in infl iximab-treated patients. J Infect 2007;55: 484-7.
21. Winthrop KL, McNelley E, Kendall B, Marshall-Olson A, Morris C, Cassidy M, et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med 2010;182:977-82.
22. Seitz AE, Olivier KN, Steiner CA, Montes de Oca R, Holland SM, Prevots DR. Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006. Chest 2010;138:944-9.
23. Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002;23:553-67.
24. Sakatani M. The non-tuberculous mycobacteriosis. Kekkaku 2005;80:25-30.